How systemic racism affects cognitive aging in patients with end-stage renal disease

Structural Racism, Resilience, and Premature Cognitive Aging in End-stage Renal Disease

NIH-funded research New York University School of Medicine · NIH-11080355

This study is looking at how racism affects brain health in Black patients with severe kidney disease, aiming to understand why some people experience faster cognitive decline and how others manage to stay resilient, so we can find better ways to support their health.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionNew York University School of Medicine NIH-funded
Lab location1 site (New York, United States)
Project IDNIH-11080355 on NIH RePORTER

What this research studies

This research investigates the relationship between systemic racism and cognitive aging in patients with end-stage renal disease (ESRD). It focuses on understanding how structural, institutional, and interpersonal racism contributes to cognitive impairment, particularly in Black ESRD patients. The study aims to identify mechanisms that lead to premature cognitive aging and resilience among these patients, using a comprehensive approach that includes measuring the impact of racism on health outcomes. By analyzing data from various age groups, the research seeks to inform interventions and policies that could mitigate the effects of cognitive decline associated with ESRD.

Who could benefit from this research

Good fit: Ideal candidates for this research are Black adults aged 21 and older who are living with end-stage renal disease.

Not a fit: Patients who do not have end-stage renal disease or those outside the age range of 21 and older may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to targeted interventions that improve cognitive health and quality of life for Black patients with end-stage renal disease.

How similar studies have performed: While the specific focus on systemic racism and cognitive aging in ESRD patients is novel, related research has shown that addressing health disparities can lead to improved outcomes in other populations.

Where this research is happening

New York, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Alzheimer disease dementia
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.